miR-342-5p as a Potential Regulator of HER2 Breast Cancer Cell Growth

Evita Maria Lindholm, Suvi Katri Leivonen, Eldri Undlien, Daniel Nebdal, Anna Git, Carlos Caldas, Anne Lise Børresen-Dale, Kristine Kleivi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

BACKGROUND: HER2 positive Breast Cancers (BC) have aggressive behavior and poor prognosis. Previously, we have identified miR-342-5p as an upstream regulator of HER2 signaling, as well as inhibitor of HER2 positive BC cell line growth. OBJECTIVE: Here, we aimed to further investigate the molecular mechanisms behind miR-342-5pinduced HER2 pathway deregulation. METHOD: Two HER2 amplified breast cancer cell lines were transiently transfected with miR-342-5p mimic or negative control, and gene expression was analyzed by Agilent microarrays. Three clinical datasets with BC patients were used to identify correlations between candidate genes and miR-342- 5p, and associations with survival. RESULTS: Pathway analyses of all deregulated genes revealed a significant suppression of the HER2 downstream pathways ERK/MAPK and SAPK/JNK, whereas the miR-342-5p predicted target genes were enriched for pathways associated with cell motility.Biological functions linked to mitochondrial stability were ranked among the top toxicological functions in both gene lists. Among the most deregulated genes, Cytochrome B5 Reductase 3 (CYB5R3) and Rap Guanine Nucleotide Exchange Factor 6 (RAPGEF6) significantly anticorrelated and correlated, respectively, with miR-342-5p in all three clinical BC datasets. Low CYB5R3 levels and high RAPGEF6 levels were significantly associated with survival, although this was not directly associated with HER2 expression. CONCLUSION: Our data suggest that miR-342-5p overexpression in HER2 positive BC cell lines elicits broad effects on HER2 downstream signaling, cell motility and mitochondrial stability. Together these effects may render cells less proliferative and more sensitive to cellular stress.

Original languageEnglish (US)
Pages (from-to)155-165
Number of pages11
JournalMicroRNA (Shariqah, United Arab Emirates)
Volume8
Issue number2
DOIs
StatePublished - Jan 1 2019

Fingerprint

Breast Neoplasms
Growth
Cytochrome Reductases
Guanine Nucleotide Exchange Factors
Cytochromes b5
Genes
Cell Line
Cell Movement
Survival
MAP Kinase Signaling System
Toxicology
Gene Expression
Datasets

Keywords

  • CYB5R3
  • HER2 signaling
  • MAPK
  • RAPGEF6
  • miR-342-5p
  • non-coding.

ASJC Scopus subject areas

  • Medicine(all)

Cite this

miR-342-5p as a Potential Regulator of HER2 Breast Cancer Cell Growth. / Lindholm, Evita Maria; Leivonen, Suvi Katri; Undlien, Eldri; Nebdal, Daniel; Git, Anna; Caldas, Carlos; Børresen-Dale, Anne Lise; Kleivi, Kristine.

In: MicroRNA (Shariqah, United Arab Emirates), Vol. 8, No. 2, 01.01.2019, p. 155-165.

Research output: Contribution to journalArticle

Lindholm, Evita Maria ; Leivonen, Suvi Katri ; Undlien, Eldri ; Nebdal, Daniel ; Git, Anna ; Caldas, Carlos ; Børresen-Dale, Anne Lise ; Kleivi, Kristine. / miR-342-5p as a Potential Regulator of HER2 Breast Cancer Cell Growth. In: MicroRNA (Shariqah, United Arab Emirates). 2019 ; Vol. 8, No. 2. pp. 155-165.
@article{abbf0a0e3a7a45589e74f030798aac0e,
title = "miR-342-5p as a Potential Regulator of HER2 Breast Cancer Cell Growth",
abstract = "BACKGROUND: HER2 positive Breast Cancers (BC) have aggressive behavior and poor prognosis. Previously, we have identified miR-342-5p as an upstream regulator of HER2 signaling, as well as inhibitor of HER2 positive BC cell line growth. OBJECTIVE: Here, we aimed to further investigate the molecular mechanisms behind miR-342-5pinduced HER2 pathway deregulation. METHOD: Two HER2 amplified breast cancer cell lines were transiently transfected with miR-342-5p mimic or negative control, and gene expression was analyzed by Agilent microarrays. Three clinical datasets with BC patients were used to identify correlations between candidate genes and miR-342- 5p, and associations with survival. RESULTS: Pathway analyses of all deregulated genes revealed a significant suppression of the HER2 downstream pathways ERK/MAPK and SAPK/JNK, whereas the miR-342-5p predicted target genes were enriched for pathways associated with cell motility.Biological functions linked to mitochondrial stability were ranked among the top toxicological functions in both gene lists. Among the most deregulated genes, Cytochrome B5 Reductase 3 (CYB5R3) and Rap Guanine Nucleotide Exchange Factor 6 (RAPGEF6) significantly anticorrelated and correlated, respectively, with miR-342-5p in all three clinical BC datasets. Low CYB5R3 levels and high RAPGEF6 levels were significantly associated with survival, although this was not directly associated with HER2 expression. CONCLUSION: Our data suggest that miR-342-5p overexpression in HER2 positive BC cell lines elicits broad effects on HER2 downstream signaling, cell motility and mitochondrial stability. Together these effects may render cells less proliferative and more sensitive to cellular stress.",
keywords = "CYB5R3, HER2 signaling, MAPK, RAPGEF6, miR-342-5p, non-coding.",
author = "Lindholm, {Evita Maria} and Leivonen, {Suvi Katri} and Eldri Undlien and Daniel Nebdal and Anna Git and Carlos Caldas and B{\o}rresen-Dale, {Anne Lise} and Kristine Kleivi",
year = "2019",
month = "1",
day = "1",
doi = "10.2174/2211536608666181206124922",
language = "English (US)",
volume = "8",
pages = "155--165",
journal = "MicroRNA (Shāriqah, United Arab Emirates)",
issn = "2211-5366",
publisher = "Bentham Science Publishers",
number = "2",

}

TY - JOUR

T1 - miR-342-5p as a Potential Regulator of HER2 Breast Cancer Cell Growth

AU - Lindholm, Evita Maria

AU - Leivonen, Suvi Katri

AU - Undlien, Eldri

AU - Nebdal, Daniel

AU - Git, Anna

AU - Caldas, Carlos

AU - Børresen-Dale, Anne Lise

AU - Kleivi, Kristine

PY - 2019/1/1

Y1 - 2019/1/1

N2 - BACKGROUND: HER2 positive Breast Cancers (BC) have aggressive behavior and poor prognosis. Previously, we have identified miR-342-5p as an upstream regulator of HER2 signaling, as well as inhibitor of HER2 positive BC cell line growth. OBJECTIVE: Here, we aimed to further investigate the molecular mechanisms behind miR-342-5pinduced HER2 pathway deregulation. METHOD: Two HER2 amplified breast cancer cell lines were transiently transfected with miR-342-5p mimic or negative control, and gene expression was analyzed by Agilent microarrays. Three clinical datasets with BC patients were used to identify correlations between candidate genes and miR-342- 5p, and associations with survival. RESULTS: Pathway analyses of all deregulated genes revealed a significant suppression of the HER2 downstream pathways ERK/MAPK and SAPK/JNK, whereas the miR-342-5p predicted target genes were enriched for pathways associated with cell motility.Biological functions linked to mitochondrial stability were ranked among the top toxicological functions in both gene lists. Among the most deregulated genes, Cytochrome B5 Reductase 3 (CYB5R3) and Rap Guanine Nucleotide Exchange Factor 6 (RAPGEF6) significantly anticorrelated and correlated, respectively, with miR-342-5p in all three clinical BC datasets. Low CYB5R3 levels and high RAPGEF6 levels were significantly associated with survival, although this was not directly associated with HER2 expression. CONCLUSION: Our data suggest that miR-342-5p overexpression in HER2 positive BC cell lines elicits broad effects on HER2 downstream signaling, cell motility and mitochondrial stability. Together these effects may render cells less proliferative and more sensitive to cellular stress.

AB - BACKGROUND: HER2 positive Breast Cancers (BC) have aggressive behavior and poor prognosis. Previously, we have identified miR-342-5p as an upstream regulator of HER2 signaling, as well as inhibitor of HER2 positive BC cell line growth. OBJECTIVE: Here, we aimed to further investigate the molecular mechanisms behind miR-342-5pinduced HER2 pathway deregulation. METHOD: Two HER2 amplified breast cancer cell lines were transiently transfected with miR-342-5p mimic or negative control, and gene expression was analyzed by Agilent microarrays. Three clinical datasets with BC patients were used to identify correlations between candidate genes and miR-342- 5p, and associations with survival. RESULTS: Pathway analyses of all deregulated genes revealed a significant suppression of the HER2 downstream pathways ERK/MAPK and SAPK/JNK, whereas the miR-342-5p predicted target genes were enriched for pathways associated with cell motility.Biological functions linked to mitochondrial stability were ranked among the top toxicological functions in both gene lists. Among the most deregulated genes, Cytochrome B5 Reductase 3 (CYB5R3) and Rap Guanine Nucleotide Exchange Factor 6 (RAPGEF6) significantly anticorrelated and correlated, respectively, with miR-342-5p in all three clinical BC datasets. Low CYB5R3 levels and high RAPGEF6 levels were significantly associated with survival, although this was not directly associated with HER2 expression. CONCLUSION: Our data suggest that miR-342-5p overexpression in HER2 positive BC cell lines elicits broad effects on HER2 downstream signaling, cell motility and mitochondrial stability. Together these effects may render cells less proliferative and more sensitive to cellular stress.

KW - CYB5R3

KW - HER2 signaling

KW - MAPK

KW - RAPGEF6

KW - miR-342-5p

KW - non-coding.

UR - http://www.scopus.com/inward/record.url?scp=85062630744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062630744&partnerID=8YFLogxK

U2 - 10.2174/2211536608666181206124922

DO - 10.2174/2211536608666181206124922

M3 - Article

C2 - 30520388

AN - SCOPUS:85062630744

VL - 8

SP - 155

EP - 165

JO - MicroRNA (Shāriqah, United Arab Emirates)

JF - MicroRNA (Shāriqah, United Arab Emirates)

SN - 2211-5366

IS - 2

ER -